Theravance Biopharma, Inc. — Form 4
Filed July 8, 2026 · analyzed by the Insider Agent
4
— Neutral
significance 20/100
What the filing says
Insider 4 filing for Theravance Biopharma, Inc..
Why this rating
Insider filing.
See more from July 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.